Finance

Lists
Why is BLTE up 3,05%?
Dive Deeper
BLTE:NASDAQ
Belite Bio Inc
159,20 USD
+3,05%
(+4,71) 1D
12-окт., 11:53:43 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BLTE...
Open
154,95 USD
High
160,74 USD
Low
154,63 USD
Mkt. cap
6,41 млд
Avg. vol.
195,05 миң
Volume
88,26 миң
52-wk high
200,00 USD
52-wk low
78,71 USD
EPS
-2,85 USD
Beta
-1,23
Shares outstanding
40,27 млн
No. of employees
41
Open
154,95 USD
High
160,74 USD
Low
154,63 USD
Mkt. cap
6,41 млд
Avg. vol.
195,05 миң
Volume
88,26 миң
52-wk high
200,00 USD
52-wk low
78,71 USD
EPS
-2,85 USD
Beta
-1,23
Shares outstanding
40,27 млн
No. of employees
41
News stories
From web sources and news partners
About Belite Bio Inc
CEO-
Employees41
Founded2016
Headquarters-
SectorPharmaceutical industry
Websitebelitebio.com
Analyst ratings
Based on 7 analysts giving stock ratings to BLTE in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for BLTE in the last 3 months.
Highest
Current 159,20 USD
303,00 USD (+90,33%)
Average
236,86 USD (+48,78%)
Lowest
200,00 USD (+25,63%)
Analyst
Recommendation
Action
Price target
Projected
Date
Graig Suvannavejh
Mizuho Securities
Buy
Maintained
234,00 USD
+47%
09/09/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
245,00 USD
+53,9%
09/09/2026
Whitney Ijem
Canaccord Genuity
Buy
Initiated
303,00 USD
+90,3%
09/04/2026
Tazeen Ahmad
Bank of America Securities
Buy
Maintained
200,00 USD
+25,6%
09/02/2026
Judah Frommer
Morgan Stanley
Buy
Maintained
206,00 USD
+29,4%
08/17/2026
Michael Okunewitch
Maxim Group
Buy
Maintained
200,00 USD
+25,6%
08/14/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
270,00 USD
+69,6%
08/14/2026
Bruce Jackson
Benchmark Co.
Buy
Maintained
217,00 USD
+36,3%
03/03/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
10,31 млн
14,62 млн
15,66 млн
18,21 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12,71 млн
13,45 млн
17,02 млн
16,69 млн
Operating expense
23,02 млн
28,08 млн
32,68 млн
34,91 млн
Total operating expenses
23,02 млн
28,08 млн
32,68 млн
34,91 млн
Operating income
-23,02 млн
-28,08 млн
-32,68 млн
-34,91 млн
Other non operating income
-2,14 млн
-417,00 миң
5,75 млн
6,55 млн
EBT including unusual items
-21,69 млн
-25,32 млн
-26,94 млн
-28,36 млн
EBT excluding unusual items
-21,69 млн
-25,32 млн
-26,94 млн
-28,36 млн
Income tax expense
-
-
-
55,00 миң
Effective tax rate
-
-
-
-0,19%
Other operating expenses
-
-
-
-
Net income
-21,69 млн
-25,32 млн
-26,94 млн
-28,41 млн
Net profit margin
-
-
-
-
Earnings per share
-0,65
-0,70
-0,68
-0,70
Interest and investment income
3,47 млн
3,17 млн
-
-
Interest expense
-
-2,00 миң
-
-
Net interest expenses
3,47 млн
3,17 млн
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-22,97 млн
-28,03 млн
-32,64 млн
-34,86 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору